XML 177 R2.htm IDEA: XBRL DOCUMENT
v3.25.1

Pay vs Performance Disclosure | 1 Months Ended | 2 Months Ended | 10 Months Ended | 11 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Jan. 31, 2021 USD ($) | Dec. 31, 2024 USD ($) | Oct. 17, 2024 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2024 USD ($) $ / shares | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares | Dec. 31, 2021 USD ($) $ / shares | Dec. 31, 2020 USD ($) $ / shares
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure, Table |  |  |  |  |  | # Pay Versus Performance As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, and Item 402(v) of Regulation S-K, which was adopted by the SEC in 2022, we are providing the following information regarding the relationship between compensation actually paid (“CAP”) to our principal executive officer (“PEO”) and Non-PEO NEOs and certain financial performance measures of the Company for the fiscal years listed below. The data included in the CAP columns does not reflect the actual amount of compensation earned or paid to our NEOs during the applicable fiscal year and it is reported solely pursuant to SEC rules. The CAP amount also does not represent amounts that have actually been earned or realized, including in respect of PSUs, RSUs and options. Performance conditions for many of these equity awards have either not yet been satisfied or applicable performance information is not yet available. To this end, information in the table may not reflect whether compensation actually realized is aligned with performance. The MP&D Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown. For additional information about our performance-based pay philosophy and how we align executive compensation with CVS Health’s performance, refer to the CD&A beginning on page 47. Adjusted Earnings Per Share.
|  | SCT Table |  | SCT Table Total for |  | SCT Table |  | Compensation Actually |  | Compensation Actually Paid |  | Compensation Actually |  | Average Summary Compensation Table Total |  | Average Compensation Actually Paid |  | Value of Initial Fixed $100 Investment based on:(5) |  |  |  |
Year |  | Total for First PEO(1)(2) ($) |  | Second PEO(1)(2) ($) |  | Total for Third PEO(1)(2) ($) |  | Paid to First PEO(1)(2)(3)(4) ($) |  | to Second PEO(1)(2)(3)(4) ($) |  | Paid to Third PEO(1)(2)(3) ($) |  | for Non-PEO NEOs(1)(2) ($) |  | to Non-PEO NEOs(1)(2)(3)(4) ($) |  | TSR ($) |  | Peer Group TSR ($) |  | Net Income ($ Millions) |  | Adj. EPS ($)(6)
(a) |  | (b) |  | (b) |  | (b) |  | (c) |  | (c) |  | (c) |  | (d) |  | (e) |  | (f) |  | (g) |  | (h) |  | (i)
2024 |  | 17,808,792 |  | 23,431,466 |  | — |  | 4,812,998 |  | (15,063,925) |  | — |  | 9,780,578 |  | 491,313 |  | 70.41 |  | 146.87 |  | 4,586 |  | 5.42
2023 |  | — |  | 21,615,034 |  | — |  | — |  | 7,497,241 |  | — |  | 9,284,957 |  | 7,685,990 |  | 118.83 |  | 143.18 |  | 8,368 |  | 8.74
2022 |  | — |  | 21,317,055 |  | — |  | — |  | 23,768,152 |  | — |  | 12,155,385 |  | 11,816,298 |  | 135.85 |  | 140.29 |  | 4,327 |  | 9.03
2021 |  | — |  | 20,388,412 |  | 3,784,072 |  | — |  | 66,324,077 |  | 52,818,429 |  | 11,876,865 |  | 38,197,569 |  | 147.06 |  | 143.09 |  | 7,989 |  | 8.34
2020 |  | — |  | — |  | 23,043,822 |  | — |  | — |  | 8,793,328 |  | 10,175,614 |  | 9,988,123 |  | 94.95 |  | 113.45 |  | 7,192 |  | 7.50
(1) | First PEO refers to J. David Joyner, our current PEO, who became our PEO on October 17, 2024. Second PEO refers to Karen S. Lynch who was our PEO during the period from February 1, 2021 to October 17, 2024. Third PEO refers to Larry J. Merlo who was our PEO during the period from January 1, 2020 to January 31, 2021. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
2024 |  | 2023 |  | 2022 |  | 2021 |  | 2020
Thomas F. Cowhey |  | Thomas F. Cowhey |  | Shawn M. Guertin |  | Shawn M. Guertin |  | Karen S. Lynch
Heidi B. Capozzi |  | Samrat S. Khichi |  | Alan M. Lotvin |  | Troyen A. Brennan |  | Eva C. Boratto
Tilak Mandadi |  | Tilak Mandadi |  | Tilak Mandadi |  | Alan M. Lotvin |  | Alan M. Lotvin
Prem S. Shah |  | Prem S. Shah |  | Prem S. Shah |  | Jonathan C. Roberts |  | Jonathan C. Roberts
|  | Shawn M. Guertin |  |  |  | Eva C. Boratto |  |
(2) | The amounts reported in columns (b) are the amounts of total compensation reported for the PEOs for each corresponding year in the “Total” column of the SCT. The amounts reported in column (d) represent the average of the amounts of total compensation reported for our non-PEO NEOs, as a group, for each corresponding year in the “Total” column of the SCT.
(3) | The amounts shown for CAP in columns (c) have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized or received by the Company’s NEOs. These amounts reflect the “Total” column of the SCT for the applicable year with certain adjustments as required by Item 402(v) of Regulation S-K, which are set forth below.
(4) | CAP reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the “Exclusion of Stock Awards and Option Awards” column are the totals from the “Stock Awards” and “Option Awards” columns set forth in the SCT. Amounts in the “Exclusion of Change in Pension Value” column reflect the amounts attributable to the change in pension value reported in the SCT. Because the Aetna Pension Plan is frozen, there is no adjustment for the service cost for services rendered during the listed year.
(5) | The Peer Group TSR set forth in this column utilizes the S&P 500 Healthcare Group Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2024 Form 10-K. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the S&P 500 Healthcare Group Index, respectively. Historical stock performance is not necessarily indicative of future performance.
(6) | While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that Adjusted EPS is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link CAP to the Company’s NEOs, for the most recently completed fiscal year, to Company performance. This performance measure may not have been the most important financial performance measure for prior years and we may determine a different financial performance measure to be the most important financial performance measure in future years. Adjusted EPS is a non-GAAP financial measure. See Annex A to this proxy statement for an explanation and a reconciliation to the most comparable GAAP financial measure.
(1) | First PEO refers to J. David Joyner, our current PEO, who became our PEO on October 17, 2024. Second PEO refers to Karen S. Lynch who was our PEO during the period from February 1, 2021 to October 17, 2024. Third PEO refers to Larry J. Merlo who was our PEO during the period from January 1, 2020 to January 31, 2021. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
2024 |  | 2023 |  | 2022 |  | 2021 |  | 2020
Thomas F. Cowhey |  | Thomas F. Cowhey |  | Shawn M. Guertin |  | Shawn M. Guertin |  | Karen S. Lynch
Heidi B. Capozzi |  | Samrat S. Khichi |  | Alan M. Lotvin |  | Troyen A. Brennan |  | Eva C. Boratto
Tilak Mandadi |  | Tilak Mandadi |  | Tilak Mandadi |  | Alan M. Lotvin |  | Alan M. Lotvin
Prem S. Shah |  | Prem S. Shah |  | Prem S. Shah |  | Jonathan C. Roberts |  | Jonathan C. Roberts
|  | Shawn M. Guertin |  |  |  | Eva C. Boratto |  |
(2) | The amounts reported in columns (b) are the amounts of total compensation reported for the PEOs for each corresponding year in the “Total” column of the SCT. The amounts reported in column (d) represent the average of the amounts of total compensation reported for our non-PEO NEOs, as a group, for each corresponding year in the “Total” column of the SCT.
(3) | The amounts shown for CAP in columns (c) have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized or received by the Company’s NEOs. These amounts reflect the “Total” column of the SCT for the applicable year with certain adjustments as required by Item 402(v) of Regulation S-K, which are set forth below.
(4) | CAP reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the “Exclusion of Stock Awards and Option Awards” column are the totals from the “Stock Awards” and “Option Awards” columns set forth in the SCT. Amounts in the “Exclusion of Change in Pension Value” column reflect the amounts attributable to the change in pension value reported in the SCT. Because the Aetna Pension Plan is frozen, there is no adjustment for the service cost for services rendered during the listed year.
PEO 1 SCT Total to CAP Reconciliation
Year |  | Summary Compensation Table Total for First PEO ($) |  | Exclusion of Change in Pension Value for First PEO ($) |  | Exclusion of Stock Awards and Option Awards for First PEO ($) |  | Inclusion of Pension Service Cost for First PEO ($) |  | Inclusion of Equity Values for First PEO ($) |  | Compensation Actually Paid to First PEO ($)
2024 |  | 17,808,792 |  | — |  | (16,499,887) |  | — |  | 3,504,093 |  | 4,812,998
Year |  | Summary Compensation Table Total for Second PEO ($) |  | Exclusion of Change in Pension Value for Second PEO ($) |  | Exclusion of Stock Awards and Option Awards for Second PEO ($) |  | Inclusion of Pension Service Cost for Second PEO ($) |  | Inclusion of Equity Values for Second PEO ($) |  | Compensation Actually Paid to Second PEO ($)
2024 |  | 23,431,466 |  | — |  | (17,999,842) |  | — |  | (20,495,549) |  | (15,063,925)
Year |  | Average Summary Compensation Table Total for Non-PEO NEOs ($) |  | Average Exclusion of Change in Pension Value for Non-PEO NEOs ($) |  | Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs ($) |  | Average Inclusion of Pension Service Cost for Non-PEO NEOs ($) |  | Average Inclusion of Equity Values for Non- PEO NEOs ($) |  | Average Compensation Actually Paid to Non- PEO NEOs ($)
2024 |  | 9,780,578 |  | (428) |  | (8,124,869) |  | — |  | (1,163,969) |  | 491,313
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
Year |  | Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for First PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for First PEO ($) |  | Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for First PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for First PEO ($) |  | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for First PEO ($) |  | Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for First PEO ($) |  | Total – Inclusion of Equity Values for First PEO ($)
2024 |  | 7,575,120 |  | (4,040,596) |  | — |  | (30,431) |  | — |  | — |  | 3,504,093
Year |  | Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Second PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Second PEO ($) |  | Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Second PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Second PEO ($) |  | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Second PEO ($) |  | Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for Second PEO ($) |  | Total – Inclusion of Equity Values for Second PEO ($)
2024 |  | 7,128,548 |  | (27,616,271) |  | — |  | (7,826) |  | — |  | — |  | (20,495,549)
Year |  | Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs ($) |  | Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs ($) |  | Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Non-PEO NEOs ($) |  | Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs ($) |  | Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs ($) |  | Average Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for Non-PEO NEOs ($) |  | Total – Average Inclusion of Equity Values for Non-PEO NEOs ($)
2024 |  | 4,092,665 |  | (5,056,618) |  | 0 |  | (200,016) |  | 0 |  | 0 |  | (1,163,969)
(5) | The Peer Group TSR set forth in this column utilizes the S&P 500 Healthcare Group Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2024 Form 10-K. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the S&P 500 Healthcare Group Index, respectively. Historical stock performance is not necessarily indicative of future performance.
(6) | While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that Adjusted EPS is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link CAP to the Company’s NEOs, for the most recently completed fiscal year, to Company performance. This performance measure may not have been the most important financial performance measure for prior years and we may determine a different financial performance measure to be the most important financial performance measure in future years. Adjusted EPS is a non-GAAP financial measure. See Annex A to this proxy statement for an explanation and a reconciliation to the most comparable GAAP financial measure.
Company Selected Measure Name |  |  |  |  |  | Adjusted Earnings Per Share. |  |  |  |
Named Executive Officers, Footnote [Text Block] |  |  |  |  |  |
(1) | First PEO refers to J. David Joyner, our current PEO, who became our PEO on October 17, 2024. Second PEO refers to Karen S. Lynch who was our PEO during the period from February 1, 2021 to October 17, 2024. Third PEO refers to Larry J. Merlo who was our PEO during the period from January 1, 2020 to January 31, 2021. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
2024 |  | 2023 |  | 2022 |  | 2021 |  | 2020
Thomas F. Cowhey |  | Thomas F. Cowhey |  | Shawn M. Guertin |  | Shawn M. Guertin |  | Karen S. Lynch
Heidi B. Capozzi |  | Samrat S. Khichi |  | Alan M. Lotvin |  | Troyen A. Brennan |  | Eva C. Boratto
Tilak Mandadi |  | Tilak Mandadi |  | Tilak Mandadi |  | Alan M. Lotvin |  | Alan M. Lotvin
Prem S. Shah |  | Prem S. Shah |  | Prem S. Shah |  | Jonathan C. Roberts |  | Jonathan C. Roberts
|  | Shawn M. Guertin |  |  |  | Eva C. Boratto |  |
Peer Group Issuers, Footnote |  |  |  |  |  | The Peer Group TSR set forth in this column utilizes the S&P 500 Healthcare Group Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2024 Form 10-K |  |  |  |
Adjustment To PEO Compensation, Footnote |  |  |  |  |  | PEO 1 SCT Total to CAP Reconciliation
Year |  | Summary Compensation Table Total for First PEO ($) |  | Exclusion of Change in Pension Value for First PEO ($) |  | Exclusion of Stock Awards and Option Awards for First PEO ($) |  | Inclusion of Pension Service Cost for First PEO ($) |  | Inclusion of Equity Values for First PEO ($) |  | Compensation Actually Paid to First PEO ($)
2024 |  | 17,808,792 |  | — |  | (16,499,887) |  | — |  | 3,504,093 |  | 4,812,998
Year |  | Summary Compensation Table Total for Second PEO ($) |  | Exclusion of Change in Pension Value for Second PEO ($) |  | Exclusion of Stock Awards and Option Awards for Second PEO ($) |  | Inclusion of Pension Service Cost for Second PEO ($) |  | Inclusion of Equity Values for Second PEO ($) |  | Compensation Actually Paid to Second PEO ($)
2024 |  | 23,431,466 |  | — |  | (17,999,842) |  | — |  | (20,495,549) |  | (15,063,925)
Year |  | Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for First PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for First PEO ($) |  | Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for First PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for First PEO ($) |  | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for First PEO ($) |  | Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for First PEO ($) |  | Total – Inclusion of Equity Values for First PEO ($)
2024 |  | 7,575,120 |  | (4,040,596) |  | — |  | (30,431) |  | — |  | — |  | 3,504,093
Year |  | Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Second PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Second PEO ($) |  | Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Second PEO ($) |  | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Second PEO ($) |  | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Second PEO ($) |  | Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for Second PEO ($) |  | Total – Inclusion of Equity Values for Second PEO ($)
2024 |  | 7,128,548 |  | (27,616,271) |  | — |  | (7,826) |  | — |  | — |  | (20,495,549)
Non-PEO NEO Average Total Compensation Amount | [1],[2] |  |  |  |  | $ 9,780,578 | $ 9,284,957 | $ 12,155,385 | $ 11,876,865 | $ 10,175,614
Non-PEO NEO Average Compensation Actually Paid Amount | [1],[2],[3],[4] |  |  |  |  | $ 491,313 | 7,685,990 | 11,816,298 | 38,197,569 | 9,988,123
Adjustment to Non-PEO NEO Compensation Footnote |  |  |  |  |  |
Year |  | Average Summary Compensation Table Total for Non-PEO NEOs ($) |  | Average Exclusion of Change in Pension Value for Non-PEO NEOs ($) |  | Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs ($) |  | Average Inclusion of Pension Service Cost for Non-PEO NEOs ($) |  | Average Inclusion of Equity Values for Non- PEO NEOs ($) |  | Average Compensation Actually Paid to Non- PEO NEOs ($)
2024 |  | 9,780,578 |  | (428) |  | (8,124,869) |  | — |  | (1,163,969) |  | 491,313
Year |  | Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs ($) |  | Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs ($) |  | Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Non-PEO NEOs ($) |  | Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs ($) |  | Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs ($) |  | Average Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for Non-PEO NEOs ($) |  | Total – Average Inclusion of Equity Values for Non-PEO NEOs ($)
2024 |  | 4,092,665 |  | (5,056,618) |  | 0 |  | (200,016) |  | 0 |  | 0 |  | (1,163,969)
Compensation Actually Paid vs. Total Shareholder Return |  |  |  |  |  |
1. | CAP versus Company TSR and Peer Group TSR
| The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs, Company TSR and Peer Group TSR for the applicable reporting year.
PEOs and Average Non-PEO NEO CAP Versus CVS Health Corporation TSR and Peer Group TSR |  |  |  |
Compensation Actually Paid vs. Net Income |  |  |  |  |  |
2. | CAP versus Net Income
| The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs and the Company’s GAAP Net Income for the applicable reporting year.
PEOs and Average Non-PEO NEO CAP Versus Net Income |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  |  |  |  |
3. | CAP versus Adjusted EPS*
The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs and Adjusted EPS for the applicable reporting year. PEOs and Average Non-PEO NEO CAP Versus Adjusted EPS |  |  |  |
Total Shareholder Return Vs Peer Group |  |  |  |  |  |
1. | CAP versus Company TSR and Peer Group TSR
| The graph below reflects the relationship between the CAP to the PEOs and Non-PEO NEOs, Company TSR and Peer Group TSR for the applicable reporting year.
PEOs and Average Non-PEO NEO CAP Versus CVS Health Corporation TSR and Peer Group TSR |  |  |  |
Tabular List, Table |  |  |  |  |  | #### Most Important Measures to Determine FY2024 CAP The Company’s executive compensation program supports our long-term strategy by tying the vast majority of pay for executives to performance-based compensation. The three items listed below represent an unranked list of the most important performance metrics used by the Company for linking executive compensation actually paid to the NEOs for 2024 and Company performance, as further described in our CD&A within the sections titled “Elements of Our Executive Compensation Program,” “Long-Term Incentive Compensation” and “2024 Business and Performance Results.”
Adjusted Earnings Per Share* Adjusted Operating Income TSR
* | Adjusted EPS and Adjusted Operating Income are non-GAAP financial measures. See Annex A to this proxy statement for an explanation and a reconciliation to the most comparable GAAP financial measures.
Total Shareholder Return Amount | [5] |  |  |  |  | $ 70.41 | 118.83 | 135.85 | 147.06 | 94.95
Peer Group Total Shareholder Return Amount | [5] |  |  |  |  | 146.87 | 143.18 | 140.29 | 143.09 | 113.45
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest |  |  |  |  |  | $ 4,586,000,000 | $ 8,368,000,000 | $ 4,327,000,000 | $ 7,989,000,000 | $ 7,192,000,000
Company Selected Measure Amount | $ / shares | [6] |  |  |  |  | 5.42 | 8.74 | 9.03 | 8.34 | 7.50
PEO Name |  | Larry J. Merlo | J. David Joyner | Karen S. Lynch | Karen S. Lynch |  | Karen S. Lynch | Karen S. Lynch |  | Larry J. Merlo
Additional 402(v) Disclosure |  |  |  |  |  | As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, and Item 402(v) of Regulation S-K, which was adopted by the SEC in 2022, we are providing the following information regarding the relationship between compensation actually paid (“CAP”) to our principal executive officer (“PEO”) and Non-PEO NEOs and certain financial performance measures of the Company for the fiscal years listed below. The data included in the CAP columns does not reflect the actual amount of compensation earned or paid to our NEOs during the applicable fiscal year and it is reported solely pursuant to SEC rules. The CAP amount also does not represent amounts that have actually been earned or realized, including in respect of PSUs, RSUs and options. Performance conditions for many of these equity awards have either not yet been satisfied or applicable performance information is not yet available. To this end, information in the table may not reflect whether compensation actually realized is aligned with performance. The MP&D Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown. |  |  |  |
Measure [Axis]: 1 |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Measure Name | [7] |  |  |  |  | Adjusted Earnings Per Share |  |  |  |
Non-GAAP Measure Description |  |  |  |  |  | While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that Adjusted EPS is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link CAP to the Company’s NEOs, for the most recently completed fiscal year, to Company performance. This performance measure may not have been the most important financial performance measure for prior years and we may determine a different financial performance measure to be the most important financial performance measure in future years. Adjusted EPS is a non-GAAP financial measure. See Annex A to this proxy statement for an explanation and a reconciliation to the most comparable GAAP financial measure |  |  |  |
Measure [Axis]: 2 |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Measure Name |  |  |  |  |  | Adjusted Operating Income |  |  |  |
Measure [Axis]: 3 |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Measure Name |  |  |  |  |  | TSR |  |  |  |
Non-PEO NEO [Member] | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | $ (428) |  |  |  |
Non-PEO NEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | (8,124,869) |  |  |  |
Non-PEO NEO [Member] | Aggregate Pension Adjustments Service Cost [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | 0 |  |  |  |
Non-PEO NEO [Member] | Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | (1,163,969) |  |  |  |
Non-PEO NEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | 4,092,665 |  |  |  |
Non-PEO NEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | (5,056,618) |  |  |  |
Non-PEO NEO [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | 0 |  |  |  |
Non-PEO NEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | (200,016) |  |  |  |
Non-PEO NEO [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | 0 |  |  |  |
Non-PEO NEO [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  |  | $ 0 |  |  |  |
J. David Joyner (PEO 1) |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
PEO Total Compensation Amount | [1],[2] |  | $ 17,808,792 |  |  |  |  |  |  |
PEO Actually Paid Compensation Amount | [1],[2],[3],[4] |  | 4,812,998 |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | (16,499,887) |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Aggregate Pension Adjustments Service Cost [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | 3,504,093 |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | 7,575,120 |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | (4,040,596) |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | (30,431) |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 |  |  |  |  |  |  |
J. David Joyner (PEO 1) | PEO [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  | $ 0 |  |  |  |  |  |  |
Karen S. Lynch (PEO 2) |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
PEO Total Compensation Amount | [1],[2] |  |  | $ 23,431,466 | $ 20,388,412 |  | $ 21,615,034 | $ 21,317,055 |  |
PEO Actually Paid Compensation Amount | [1],[2],[3],[4] |  |  | (15,063,925) | $ 66,324,077 |  | $ 7,497,241 | $ 23,768,152 |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | 0 |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | (17,999,842) |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Aggregate Pension Adjustments Service Cost [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | 0 |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | (20,495,549) |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | 7,128,548 |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | (27,616,271) |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | 0 |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | (7,826) |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | 0 |  |  |  |  |  |
Karen S. Lynch (PEO 2) | PEO [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
Adjustment to Compensation Amount |  |  |  | $ 0 |  |  |  |  |  |
Larry J. Merlo (PEO 3) |  |  |  |  |  |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |  |  |  |  |  |
PEO Total Compensation Amount | [1],[2] | $ 3,784,072 |  |  |  |  |  |  |  | $ 23,043,822
PEO Actually Paid Compensation Amount | [1],[2],[4] | $ 52,818,429 |  |  |  |  |  |  |  | $ 8,793,328
[1] | First PEO refers to J. David Joyner, our current PEO, who became our PEO on October 17, 2024. Second PEO refers to Karen S. Lynch who was our PEO during the period from February 1, 2021 to October 17, 2024. Third PEO refers to Larry J. Merlo who was our PEO during the period from January 1, 2020 to January 31, 2021. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
[2] | The amounts reported in columns (b) are the amounts of total compensation reported for the PEOs for each corresponding year in the “Total” column of the SCT. The amounts reported in column (d) represent the average of the amounts of total compensation reported for our non-PEO NEOs, as a group, for each corresponding year in the “Total” column of the SCT.
[3] | CAP reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the “Exclusion of Stock Awards and Option Awards” column are the totals from the “Stock Awards” and “Option Awards” columns set forth in the SCT. Amounts in the “Exclusion of Change in Pension Value” column reflect the amounts attributable to the change in pension value reported in the SCT. Because the Aetna Pension Plan is frozen, there is no adjustment for the service cost for services rendered during the listed year.
[4] | The amounts shown for CAP in columns (c) have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized or received by the Company’s NEOs. These amounts reflect the “Total” column of the SCT for the applicable year with certain adjustments as required by Item 402(v) of Regulation S-K, which are set forth below.
[5] | The Peer Group TSR set forth in this column utilizes the S&P 500 Healthcare Group Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2024 Form 10-K. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the S&P 500 Healthcare Group Index, respectively. Historical stock performance is not necessarily indicative of future performance.
[6] | While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that Adjusted EPS is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link CAP to the Company’s NEOs, for the most recently completed fiscal year, to Company performance. This performance measure may not have been the most important financial performance measure for prior years and we may determine a different financial performance measure to be the most important financial performance measure in future years. Adjusted EPS is a non-GAAP financial measure. See Annex A to this proxy statement for an explanation and a reconciliation to the most comparable GAAP financial measure.
[7] | Adjusted EPS and Adjusted Operating Income are non-GAAP financial measures. See Annex A to this proxy statement for an explanation and a reconciliation to the most comparable GAAP financial measures.

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v + Details
Name: | ecd_Additional402vDisclosureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(16)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 19 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19 Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 31: http://www.xbrl.org/2003/role/exampleRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 4J -Publisher FASB -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 4K -Publisher FASB -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2 Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_AggtPnsnAdjsSvcCstMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=cvs_JDavidJoynerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=cvs_KarenSLynchMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=cvs_LarryJMerloMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |